{"_self":{"principle":"Self-explaining payload — no external context required. This _self block describes what you are reading and where to look next.","widget":"article_topology","feature":"topology","name":"Article topology","what":"Claims, sources, anecdotes, user reports, related embeds, question graph slice — for ask/ROUTER.","contains":"claims, sources, anecdotes, question_graph slice","slug":"nad-plus-stimulants","urls":{"read":"https://miscsubjects.com/api/articles/nad-plus-stimulants/topology"},"how_to_use":"Claims, sources, anecdotes, user reports, related embeds, question graph slice — for ask/ROUTER.","write":null,"imessage":null,"router_tag":null,"proof_chain":[{"step":1,"claim":"Articles are voxel graphs of tiered claims, not prose blobs.","verify":"https://miscsubjects.com/api/articles/constitution"},{"step":2,"claim":"Claims link to hash-chained sources via source_ids.","verify":"https://miscsubjects.com/api/articles/nad-plus-stimulants/sources"},{"step":3,"claim":"Ask reads topology; ingest/claim append to ledger.","verify":"https://miscsubjects.com/api/protocol"},{"step":4,"claim":"Models queue growth: populate → collaborate → repair → reflex.","verify":"https://miscsubjects.com/api/protocol/grow"},{"step":5,"claim":"Graph proves its own shape (reflex) and $/claim (yield).","verify":"https://miscsubjects.com/graph.html?layer=reflex"},{"step":6,"claim":"Full feature index + _explain on every API response.","verify":"https://miscsubjects.com/api/articles/system-map"}],"related_features":[{"id":"ask","name":"Ask protocol","what":"Answer only from topology; creates question_node with gaps and ingest_hint.","urls":{"read":"https://miscsubjects.com/api/articles/nad-plus-stimulants/prompts","write":"https://miscsubjects.com/api/protocol/ask"}},{"id":"graph_topology","name":"Cross-article graph","what":"Merged claims/sources across condition+stack slugs for one question.","urls":{"read":"https://miscsubjects.com/api/articles/nad-plus-stimulants/graph-topology?question=..."}},{"id":"question_graph","name":"Question graph","what":"Ask nodes (questions + gaps) and evidence_ingest nodes (pasted model output).","urls":{"read":"https://miscsubjects.com/api/articles/nad-plus-stimulants/question-graph","write":"https://miscsubjects.com/api/protocol/ask"}},{"id":"voxels","name":"Voxel graph","what":"Claims as atoms, sources as edges (supported_by, posted_by). Per-claim provenance.","urls":{"read":"https://miscsubjects.com/api/articles/nad-plus-stimulants/voxels","write":"https://miscsubjects.com/api/protocol/claim"}}],"system_map":"https://miscsubjects.com/api/articles/system-map","system_map_markdown":"https://miscsubjects.com/api/articles/system-map?format=markdown","not_medical_advice":true},"_explain":{"feature":"topology","name":"Article topology","what":"Claims, sources, anecdotes, user reports, related embeds, question graph slice — for ask/ROUTER.","why":"Every feature is auditable collective intelligence","how":"Claims, sources, anecdotes, user reports, related embeds, question graph slice — for ask/ROUTER.","model":null,"verifies":null,"urls":{"read":"https://miscsubjects.com/api/articles/nad-plus-stimulants/topology"},"imessage":null,"router":null,"related":[{"id":"ask","what":"Answer only from topology; creates question_node with gaps and ingest_hint."},{"id":"graph_topology","what":"Merged claims/sources across condition+stack slugs for one question."},{"id":"question_graph","what":"Ask nodes (questions + gaps) and evidence_ingest nodes (pasted model output)."},{"id":"voxels","what":"Claims as atoms, sources as edges (supported_by, posted_by). Per-claim provenance."}],"not_medical_advice":true},"slug":"nad-plus-stimulants","title":"NAD+ and Related Peptides for Stimulant Load: Evidence on Repair Layers","register":"source_ledger","tags":["peptide","matrix"],"updated_at":"2026-07-17T02:40:44.998Z","body_excerpt":"## What's breaking down if you have Stimulant load (Adderall / amphetamine)\n\nAmphetamines force dopamine and norepinephrine release. This borrows focus now.\n\nSleep, appetite, and gut lining often suffer. Less regeneration window follows.\n\nChronic load can deplete neurochemistry and stress the gut-brain axis.\n\nFour layers show the mismatch between breakdown and repair:\n\n- Dopamine system: Forced release leads to depletion, crash, anhedonia, and tolerance.\n- Sleep: Stimulants delay onset and cut deep sleep stages.\n- Gut: Mucosa faces stress; inflammation feeds back to mood and cognition.\n- Anxiety: Arousal without calm produces jitter, rumination, and non-restorative stress.\n\n## Why Semax might help you\n\n1. You have Stimulant load (Adderall / amphetamine) — breakdown is outpacing repair.\n2. What keeps failing: BDNF decline, stimulant-induced neuro stress, cognitive fatigue after dopamine load.\n3. What Semax is studied to do: Studied for BDNF and neural support — building connections, not sedating symptoms.\n4. Therefore for you: If that layer is part of your problem, Semax is discussed because it targets repair (neural / cognitive) — not because it masks pain.\n\n## Why Selank might help you\n\n1. You have Stimulant load (Adderall / amphetamine) — breakdown is outpacing repair.\n2. Layer breaking down: Anxiety — Arousal without calm leads to jitter, rumination, non-restorative stress.\n3. What Selank is studied to do: Studied for anxiolytic pathways without classic benzodiazepine sedation.\n4. Therefore for you: If that layer is part of your problem, Selank is discussed because it targets repair (anxiety / neurochemistry) — not because it masks pain.\n\n## Why DSIP might help you\n\n1. You have Stimulant load (Adderall / amphetamine) — breakdown is outpacing repair.\n2. Layer breaking down: Sleep — Stimulants delay sleep onset and cut deep sleep.\n3. What DSIP is studied to do: Studied for sleep architecture and deep-sleep promotion.\n4. Therefore for you: If that layer is part of your problem, DSIP is discussed because it targets repair (sleep / repair window) — not because it masks pain.\n\n## Why NAD+ might help you\n\n1. You have Stimulant load (Adderall / amphetamine) — breakdown is outpacing repair.\n2. Therefore for you: If that layer is part of your problem, NAD+ is discussed because it targets repair (tissue) — not because it masks pain.\n\n## Why Amphetamine stimulants matters for you\n\n1. Drug: Amphetamine stimulants.\n2. What it does: Forces neurotransmitter release; borrows focus at cost of sleep/gut reserve.\n3. Therefore for you: This drug suppresses signals of fatigue and suppresses repair windows. It trades short-term focus for longer-term depletion of neurochemistry and sleep architecture.\n\n## How these fit together\n\nNeural support (Semax), non-benzo calm (Selank), sleep repair window (DSIP) — each targets a stimulant-degeneration layer.\n- Semax targets neural / cognitive.\n- Selank targets anxiety / neurochemistry.\n- DSIP targets sleep / repair window.\n- NAD+ targets cellular energy.\n\nThe stack maps distinct layers without overlap in primary action. Semax addresses BDNF and dopamine-related fatigue. Selank addresses arousal excess. DSIP widens the deep-sleep window stimulants shrink. NAD+ supports mitochondrial energy that stimulants can tax. Together they address separate points where breakdown exceeds repair.\n\n## What the evidence actually shows\n\nHuman data exist for Selank in generalized anxiety disorder. One trial compared it to medazepam in 62 patients and found comparable anxiolytic effects with additional cognitive benefits (source s12). Another small trial noted rapid response in some GAD patients (source s10).\n\nSemax has animal data showing increased BDNF in rat basal forebrain and hippocampus after intranasal dosing (source s6, source s0). A hypothesis paper links this to potential ADHD relevance via dopamine and BDNF pathways (source s1). One Russian pediatric report mentioned in secondary sources noted behavioral improvemen","ranking":"safety-first (interaction_risk/limitations), then quote-gated effective_weight","claims":[{"id":"c2","text":"Selank showed anxiolytic effects comparable to medazepam in a trial of 62 GAD patients.","tier":"human","weight":0.8,"section":"Why Selank might help you","slot":null,"interaction_risk":false,"status":"active","source_ids":["s12"],"source_status":"sourced","why_material":"Provides human evidence tier for anxiety layer.","retracted_at":null,"retraction_reason":null,"challenged_by":[],"effective_weight":0.8,"quote_gated":false},{"id":"c1","text":"Semax increases BDNF levels in rat basal forebrain after intranasal application.","tier":"preclinical","weight":0.5,"section":"Why Semax might help you","slot":null,"interaction_risk":false,"status":"active","source_ids":["s6","s0"],"source_status":"sourced","why_material":"Supports neural repair layer discussion for stimulant-induced stress.","retracted_at":null,"retraction_reason":null,"challenged_by":[],"effective_weight":0.5,"quote_gated":false},{"id":"c3","text":"DSIP reduced amphetamine-induced hyperthermia in mice at certain doses.","tier":"preclinical","weight":0.5,"section":"Why DSIP might help you","slot":null,"interaction_risk":false,"status":"active","source_ids":["s15"],"source_status":"sourced","why_material":"Direct animal link to amphetamine effects.","retracted_at":null,"retraction_reason":null,"challenged_by":[],"effective_weight":0.5,"quote_gated":false},{"id":"c4","text":"NAD+ metabolism is implicated in addictive behavior and cravings in preclinical models.","tier":"preclinical","weight":0.5,"section":"Why NAD+ might help you","slot":null,"interaction_risk":false,"status":"active","source_ids":["s19"],"source_status":"sourced","why_material":"Frames cellular energy repair vs stimulant depletion.","retracted_at":null,"retraction_reason":null,"challenged_by":[],"effective_weight":0.5,"quote_gated":false},{"id":"c5","text":"Small human trials link intravenous NAD to substance use disorder recovery observations.","tier":"anecdotal","weight":0.3,"section":"What the evidence actually shows","slot":null,"interaction_risk":false,"status":"active","source_ids":["s21"],"source_status":"sourced","why_material":"Separates human observation from controlled data.","retracted_at":null,"retraction_reason":null,"challenged_by":[],"effective_weight":0.3,"quote_gated":false}],"sources":[{"id":"s0","type":"pubmed","url":"https://pubmed.ncbi.nlm.nih.gov/16996699/","title":"Semax, an analogue of adrenocorticotropin (4-10), is a potential agent for the treatment of attention-deficit hyperactivity disorder and Rett syndrome","quote":"It has been found to stimulate memory and attention in rodents and humans after intranasal application.","summary":"Reviews Semax effects including BDNF in animals.","claim_ids":["c1"],"link_status":"ok","quote_status":"verified","hash":"51dd87e0e113556ec5d9779e7cf59758164f7e2f06e94cbfc0f537cfd6b9bf2a"},{"id":"s1","type":"review","url":"https://www.sciencedirect.com/science/article/abs/pii/S0306987706005391","title":"Semax, an analogue of adrenocorticotropin (4–10), is a potential agent for the treatment of attention-deficit hyperactivity disorder","quote":"Evidence from animal studies revealed that Semax can augment the effects of psychostimulants on central dopamine release and also stimulates central brain-derived neurotrophic factor (BDNF) synthesis.","summary":"Proposes Semax for ADHD based on dopamine and BDNF data.","claim_ids":[],"link_status":"http_403","quote_status":"unverified","hash":"a3e825323e254a5b9692ae6b022a172b3ba3290c08aef75c1083e192be2a1c0c"},{"id":"s6","type":"pubmed","url":"https://pubmed.ncbi.nlm.nih.gov/16635254/","title":"Semax, an analogue of adrenocorticotropin (4-10), binds specifically to the rat basal forebrain","quote":"Sandwich immunoenzymatic analysis revealed that Semax applied intranasally at 50 and 250 microg/kg bodyweight resulted in a rapid increase in BDNF levels after 3 h in the basal forebrain","summary":"Direct rat BDNF measurement after Semax.","claim_ids":["c1"],"link_status":"ok","quote_status":"verified","hash":"103bb95be0ebdba5074bbe9eb1f3e459dd77f0354a6812445e4ad3b90613fabd"},{"id":"s12","type":"pubmed","url":"https://pubmed.ncbi.nlm.nih.gov/18454096/","title":"Efficacy and possible mechanisms of action of a new peptide anxiolytic Selank","quote":"Sixty-two patients with generalized anxiety disorder (GAD) and neurasthenia were studied. The effect of selank (30 patients) was compared to that of medazepam","summary":"Human GAD trial results.","claim_ids":["c2"],"link_status":"ok","quote_status":"verified","hash":"eb4e7d0f36c83146ac29868122a0152f698abd2bd2ff40c39437ad6f5ef5e333"},{"id":"s15","type":"pubmed","url":"https://pubmed.ncbi.nlm.nih.gov/6548818/","title":"DSIP reduces amphetamine-induced hyperthermia in mice","quote":"It was reported that DSIP reversed the increase in temperature of rats injected at room temperature with 15 mg d-amphetamine per kg body weight.","summary":"Animal thermoregulation data with amphetamine.","claim_ids":["c3"],"link_status":"ok","quote_status":"verified","hash":"d86e27e1fa46e458b88d8f6b3839ca9f6d08d3ffc9e7e0ec465ab0c1563b446f"},{"id":"s19","type":"other","url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC7278809/","title":"Sobriety and Satiety: Is NAD+ the Answer?","quote":"These studies implicate raising intracellular NAD+ levels as a potential target for managing and treating addictive behaviour and reducing cravings","summary":"Reviews NAD+ in addiction models.","claim_ids":["c4"],"link_status":"ok","quote_status":"verified","hash":"e33cbdf4c0839443ff3ef6f51ae5a232578dc850a4885d6c4530c48558f08aac"},{"id":"s21","type":"medical","url":"https://www.webmd.com/mental-health/addiction/nad-therapy-addiction","title":"NAD Therapy for Addiction: What to Know","quote":"The first study testing NAD for substance use disorders came out many decades ago. The doctor who did the study gave NAD in an IV to more than 100 people with alcohol use disorder, opioid use disorder, or other substance use disorders.","summary":"Summarizes historical NAD observations in substance issues.","claim_ids":["c5"],"link_status":"ok","quote_status":"verified","hash":"720177cd5370423ceab31b020bb4234735183b4dde2ea8cb3fd426b0a7a8263c"}],"anecdotal_sources":[],"scientific_sources":[{"id":"s0","type":"pubmed","url":"https://pubmed.ncbi.nlm.nih.gov/16996699/","title":"Semax, an analogue of adrenocorticotropin (4-10), is a potential agent for the treatment of attention-deficit hyperactivity disorder and Rett syndrome","quote":"It has been found to stimulate memory and attention in rodents and humans after intranasal application.","summary":"Reviews Semax effects including BDNF in animals.","claim_ids":["c1"],"link_status":"ok","quote_status":"verified","hash":"51dd87e0e113556ec5d9779e7cf59758164f7e2f06e94cbfc0f537cfd6b9bf2a"},{"id":"s1","type":"review","url":"https://www.sciencedirect.com/science/article/abs/pii/S0306987706005391","title":"Semax, an analogue of adrenocorticotropin (4–10), is a potential agent for the treatment of attention-deficit hyperactivity disorder","quote":"Evidence from animal studies revealed that Semax can augment the effects of psychostimulants on central dopamine release and also stimulates central brain-derived neurotrophic factor (BDNF) synthesis.","summary":"Proposes Semax for ADHD based on dopamine and BDNF data.","claim_ids":[],"link_status":"http_403","quote_status":"unverified","hash":"a3e825323e254a5b9692ae6b022a172b3ba3290c08aef75c1083e192be2a1c0c"},{"id":"s6","type":"pubmed","url":"https://pubmed.ncbi.nlm.nih.gov/16635254/","title":"Semax, an analogue of adrenocorticotropin (4-10), binds specifically to the rat basal forebrain","quote":"Sandwich immunoenzymatic analysis revealed that Semax applied intranasally at 50 and 250 microg/kg bodyweight resulted in a rapid increase in BDNF levels after 3 h in the basal forebrain","summary":"Direct rat BDNF measurement after Semax.","claim_ids":["c1"],"link_status":"ok","quote_status":"verified","hash":"103bb95be0ebdba5074bbe9eb1f3e459dd77f0354a6812445e4ad3b90613fabd"},{"id":"s12","type":"pubmed","url":"https://pubmed.ncbi.nlm.nih.gov/18454096/","title":"Efficacy and possible mechanisms of action of a new peptide anxiolytic Selank","quote":"Sixty-two patients with generalized anxiety disorder (GAD) and neurasthenia were studied. The effect of selank (30 patients) was compared to that of medazepam","summary":"Human GAD trial results.","claim_ids":["c2"],"link_status":"ok","quote_status":"verified","hash":"eb4e7d0f36c83146ac29868122a0152f698abd2bd2ff40c39437ad6f5ef5e333"},{"id":"s15","type":"pubmed","url":"https://pubmed.ncbi.nlm.nih.gov/6548818/","title":"DSIP reduces amphetamine-induced hyperthermia in mice","quote":"It was reported that DSIP reversed the increase in temperature of rats injected at room temperature with 15 mg d-amphetamine per kg body weight.","summary":"Animal thermoregulation data with amphetamine.","claim_ids":["c3"],"link_status":"ok","quote_status":"verified","hash":"d86e27e1fa46e458b88d8f6b3839ca9f6d08d3ffc9e7e0ec465ab0c1563b446f"},{"id":"s21","type":"medical","url":"https://www.webmd.com/mental-health/addiction/nad-therapy-addiction","title":"NAD Therapy for Addiction: What to Know","quote":"The first study testing NAD for substance use disorders came out many decades ago. The doctor who did the study gave NAD in an IV to more than 100 people with alcohol use disorder, opioid use disorder, or other substance use disorders.","summary":"Summarizes historical NAD observations in substance issues.","claim_ids":["c5"],"link_status":"ok","quote_status":"verified","hash":"720177cd5370423ceab31b020bb4234735183b4dde2ea8cb3fd426b0a7a8263c"}],"user_reports":[],"related_articles":[],"question_graph":{"slug":"nad-plus-stimulants","questions":[],"evidence":[],"edges":[],"counts":{"questions":0,"evidence":0,"edges":0}},"honesty":{"active_claims":5,"retracted_claims":0,"cut_claims":0,"challenges":0,"scrub_events":0,"note":"Retracted/cut claims stay on ledger but are excluded from ask unless ?include_inactive=1"},"counts":{"claims":5,"claims_total":5,"sources":7,"anecdotal":0,"scientific":6,"user_reports":0,"questions":0,"evidence_ingests":0}}